These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 26542504)
21. Hospital cost effect of a heart failure disease management program: the Specialized Primary and Networked Care in Heart Failure (SPAN-CHF) trial. Gregory D; Kimmelstiel C; Perry K; Parikh A; Konstam V; Konstam MA Am Heart J; 2006 May; 151(5):1013-8. PubMed ID: 16644325 [TBL] [Abstract][Full Text] [Related]
22. Economic Evaluation of Exercise-Based Cardiac Rehabilitation Programs for Chronic Heart Failure Patients in Colombia. Rincón M; Rojas MX; Rodriguez Romero VA; Tamayo DC; Franco C; Castro H; Brophy J; Dennis R J Cardiopulm Rehabil Prev; 2016; 36(1):12-9. PubMed ID: 26702862 [TBL] [Abstract][Full Text] [Related]
23. The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making. Palmer AJ; Roze S; Valentine WJ; Minshall ME; Foos V; Lurati FM; Lammert M; Spinas GA Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S5-26. PubMed ID: 15324513 [TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of specialized multidisciplinary heart failure clinics in Ontario, Canada. Wijeysundera HC; Machado M; Wang X; Van Der Velde G; Sikich N; Witteman W; Tu JV; Lee DS; Goodman SG; Petrella R; O'Flaherty M; Capewell S; Krahn M Value Health; 2010 Dec; 13(8):915-21. PubMed ID: 21091970 [TBL] [Abstract][Full Text] [Related]
25. The business concept of leader pricing as applied to heart failure disease management. Hauptman PJ; Bednarek HL Dis Manag; 2004; 7(3):226-34. PubMed ID: 15669582 [TBL] [Abstract][Full Text] [Related]
26. Comparison of rate control versus rhythm control for management of atrial fibrillation in patients with coexisting heart failure: a cost-effectiveness analysis. Perez A; Touchette DR; DiDomenico RJ; Stamos TD; Walton SM Pharmacotherapy; 2011 Jun; 31(6):552-65. PubMed ID: 21923439 [TBL] [Abstract][Full Text] [Related]
27. Usefulness of frailty profile for targeting older heart failure patients in disease management programs: a cost-effectiveness, pilot study. Pulignano G; Del Sindaco D; Di Lenarda A; Tarantini L; Cioffi G; Gregori D; Tinti MD; Monzo L; Minardi G J Cardiovasc Med (Hagerstown); 2010 Oct; 11(10):739-47. PubMed ID: 20736784 [TBL] [Abstract][Full Text] [Related]
28. Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure. Galbreath AD; Krasuski RA; Smith B; Stajduhar KC; Kwan MD; Ellis R; Freeman GL Circulation; 2004 Dec; 110(23):3518-26. PubMed ID: 15531765 [TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of ventricular assist device therapy as a bridge to transplantation compared with nonbridged cardiac recipients. Alba AC; Alba LF; Delgado DH; Rao V; Ross HJ; Goeree R Circulation; 2013 Jun; 127(24):2424-35. PubMed ID: 23697907 [TBL] [Abstract][Full Text] [Related]
30. A Systematic Review of the Cost-Effectiveness of Long-Term Mechanical Circulatory Support. Nunes AJ; MacArthur RG; Kim D; Singh G; Buchholz H; Chatterley P; Klarenbach SW Value Health; 2016 Jun; 19(4):494-504. PubMed ID: 27325342 [TBL] [Abstract][Full Text] [Related]
31. Two-year outcome of a prospective, controlled study of a disease management programme for elderly patients with heart failure. Del Sindaco D; Pulignano G; Minardi G; Apostoli A; Guerrieri L; Rotoloni M; Petri G; Fabrizi L; Caroselli A; Venusti R; Chiantera A; Giulivi A; Giovannini E; Leggio F J Cardiovasc Med (Hagerstown); 2007 May; 8(5):324-9. PubMed ID: 17443097 [TBL] [Abstract][Full Text] [Related]
32. Cost-utility analysis of nt-probnp-guided multidisciplinary care in chronic heart failure. Moertl D; Steiner S; Coyle D; Berger R Int J Technol Assess Health Care; 2013 Jan; 29(1):3-11. PubMed ID: 23257208 [TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of implantable cardioverter-defibrillators in Brazil: primary prevention analysis in the public sector. Ribeiro RA; Stella SF; Camey SA; Zimerman LI; Pimentel M; Rohde LE; Polanczyk CA Value Health; 2010; 13(2):160-8. PubMed ID: 19725912 [TBL] [Abstract][Full Text] [Related]
34. Financial implications of a model heart failure disease management program for providers, hospital, healthcare systems, and payer perspectives. Whellan DJ; Reed SD; Liao L; Gould SD; O'connor CM; Schulman KA Am J Cardiol; 2007 Jan; 99(2):256-60. PubMed ID: 17223429 [TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness of telephonic disease management in heart failure. Smith B; Hughes-Cromwick PF; Forkner E; Galbreath AD Am J Manag Care; 2008 Feb; 14(2):106-15. PubMed ID: 18269306 [TBL] [Abstract][Full Text] [Related]
36. Systematic review of trial-based analyses reporting the economic impact of heart failure management programs compared with usual care. Maru S; Byrnes J; Carrington MJ; Stewart S; Scuffham PA Eur J Cardiovasc Nurs; 2016 Feb; 15(1):82-90. PubMed ID: 25322749 [TBL] [Abstract][Full Text] [Related]
37. How peptide technology has improved costs and outcomes in patients with heart failure. Athanasakis K; Arista I; Balasopoulos T; Boubouchairopoulou N; Kyriopoulos J Expert Rev Pharmacoecon Outcomes Res; 2016 Jun; 16(3):371-82. PubMed ID: 27160541 [TBL] [Abstract][Full Text] [Related]
38. Economic Impact of Chronic Heart Failure Management in Today's Cost-Conscious Environment. Albert C; Estep JD Card Electrophysiol Clin; 2019 Mar; 11(1):1-9. PubMed ID: 30717841 [TBL] [Abstract][Full Text] [Related]
40. The cost-effective way forward for the management of the patient with heart failure. Giles T Cardiology; 1996; 87 Suppl 1():33-9. PubMed ID: 8681320 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]